top of page
Past Grants Recieved
Title of Research Proposal | Principal Investigator | Grant Amount | Start Date | End Date | Research Article |
|---|---|---|---|---|---|
Bacterial extracellular vesicles as a novel therapy for Parkinson’s disease | Center for Neurosciences and Cell Biology, University of Coimbra, Portugal | 5000 | 01/03/2025 | ||
Effects of prenatal infections on development of Parkinson’s disease in a model system | Center for Neurosciences and Cell Biology, University of Coimbra, Portugal | 5000 | 01/03/2025 | ||
Role of gut microbes and their metabolites in Parkinson’s disease | Stanford Hospital, Palo Alto, California | 5000 | 01/03/2022 | ||
Blood brain barrier disruption caused by gut dysbiosis in Parkinson’s disease | Centro de Inovação em Biomedicina e Biotecnologia, Coimbra, Portugal | 5000 | 01/03/2022 | https://link.springer.com/article/10.1186/s13024-024-00766-0?utm | |
Movement asymmetry and Parkinson’s disease | Applied Health Sciences, University of Waterloo, | 5000 | 01/03/2020 | https://pmc.ncbi.nlm.nih.gov/articles/PMC10393413/ | |
Quantifying brain networks with cell-type specificity to design novel therapies for Parkinson’s disease | University of Barcelona, Spain | 5000 | 01/03/2020 | https://pmc.ncbi.nlm.nih.gov/articles/PMC10696737/pdf/12987_2023_Article_494.pdf | |
LRRK2 gene interactions in Parkinson’s disease | Biomedical Research Foundation of the Academy of Athens, Greece | 5000 | 01/03/2019 | https://pmc.ncbi.nlm.nih.gov/articles/PMC7754308/pdf/MDS-35-2095.pdf | |
Intranasal delivery of pentamidine in model of Parkinson’s disease | University SAPIENZA,
Rome Italy
| 5000 | 01/03/2019 | https://air.unimi.it/retrieve/dfa8b99d-4c0d-748b-e053-3a05fe0a3a96/preprint.pdf | |
Alpha-synuclein in Parkinson’s disease | Linköping University,
Linköping, Sweden | 5000 | 01/03/2018 | https://pmc.ncbi.nlm.nih.gov/articles/PMC6570706/pdf/401_2019_Article_2007.pdf | |
Nanodelivery systems for movement disorder treatments | University of Naples Federico II, Naples, Italy | 5000 | 01/03/2018 | https://pmc.ncbi.nlm.nih.gov/articles/PMC9599564/pdf/biomedicines-10-02644.pdf | |
Detection of misfolded proteins in body fluids | NIH Rocky Mountain Laboratories, Colorado | 5000 | 01/03/2016 | https://pmc.ncbi.nlm.nih.gov/articles/PMC5806364/pdf/40478_2018_Article_508.pdf | |
Immunotherapy for Parkinson’s disease | Autonomous University of Barcelona, Spain | 5000 | 01/03/2016 | https://pmc.ncbi.nlm.nih.gov/articles/pmid/41545445/ | |
RAB39B gene in Parkinson’s disease | Murdoch Children’s Research Institute, Australia | 5000 | 01/03/2015 | https://pmc.ncbi.nlm.nih.gov/articles/PMC7106796/pdf/13041_2020_Article_584.pdf | |
Alpha-synuclein aggregation and spreading in Parkinson’s disease | University of Düsseldorf, Germany | 01/03/2015 | https://pmc.ncbi.nlm.nih.gov/articles/PMC7282669/pdf/pcbi.1007767.pdf | ||
Alpha-synuclein aggregation and spreading in Parkinson’s disease | University of Düsseldorf, Germany | 01/03/2015 | https://pmc.ncbi.nlm.nih.gov/articles/PMC6721797/pdf/elife-46112.pdf | ||
Alpha-synuclein aggregation and spreading in Parkinson’s disease | University of Düsseldorf, Germany | 5000 | 01/03/2015 | https://pmc.ncbi.nlm.nih.gov/articles/PMC7139648/pdf/ijms-21-01995.pdf | |
Alpha-synuclein aggregation and spreading in Parkinson’s disease | University of Düsseldorf, Germany | 01/03/2015 | https://www.nature.com/articles/s42003-018-0049-z?utm | ||
Alpha-synuclein aggregation and spreading in Parkinson’s disease | University of Düsseldorf, Germany | 01/03/2015 | https://www.sciencedirect.com/science/article/pii/S0009308418302135?utm | ||
Inflammation as a mechanism of Parkinson’s disease pathology | Georgetown University Medical Center, Washington, DC | 5000 | 01/03/2014 | https://pmc.ncbi.nlm.nih.gov/articles/PMC5673553/pdf/nihms906453.pdf | |
Pathology of Parkinson’s disease (degradation and elimination of proteins) | Mansoura University, Egypt | 5000 | 01/03/2014 | ||
Impaired mitochondrial dynamics underlie axonal
defects in hereditary spastic paraplegias | Department of Neurobiology, Innsbruck Medical University, Austria | 10000 | 01/03/2013 | https://pmc.ncbi.nlm.nih.gov/articles/PMC6031053/pdf/ddy156.pdf | |
Dopamine and speech deficits in Parkinson’s disease | University of Arizona | 10000 | 01/03/2013 | https://pmc.ncbi.nlm.nih.gov/articles/PMC9067653/pdf/pone.0265604.pdf | |
Pathology of SPG15 spastic paraplegia | University of Connecticut Health Science Center | 10000 | 01/03/2013 | ||
Neuropathologic and stereological assessment of dopaminergic and non-
dopaminergic neurons in the brains of dystonia patients: a specific focus on substantia nigra | Diego lacono, MD, PhD
Biomedical Research Institute of New
Jersey | 5000 | 15/01/2012 | 01/05/2012 | |
Unraveling novel pathways involved in the development and consolidation of levodopa induced Parkinson's disease | Samuel Nemanich, BS
Washington University, St Louis, MO | 5000 | 15/01/2012 | 01/05/2012 | |
Changes in autonomic function in early Parkinson's disease | David Charles, MD
Vanderbilt University Medical Center,
Nashville, TN | 5000 | 20/06/2011 | 11/07/2011 | https://pubmed.ncbi.nlm.nih.gov/22104012/ |
Functional analysis of single nucleotide genetic alterations within the promoter of genes associated with dystonia | loanna Armata, PhD
Harvard Medical School, Boston, MA | 5000 | 20/06/2011 | 11/07/2011 | https://movementdisorders.onlinelibrary.wiley.com/doi/10.1002/mds.23786 |
Toll-like receptors and lpha-synuclein in Parkinson's disease | Kathleen Maguire-Zeiss, PhD
Georgetown University Medical Center,
Washington DC | 5000 | 20/06/2011 | 11/07/2011 | https://pmc.ncbi.nlm.nih.gov/articles/PMC3500631/ |
Functional studies of the new TorsinA
mutation (R288Q) | Flavia Nery, PhD
Harvard University, Boston, MA | 5000 | 01/06/2010 | 01/07/2010 | https://pmc.ncbi.nlm.nih.gov/articles/PMC3352338/ |
Intravenous Immunoglobulin (lvlg) as a possible treatment for Parkinson's disease: effects on alpha-synuclein aggregation and neurotoxicity | David Loeffler, DVM, PhD
William Beaumont Hospital,
Royal Oak, MI | 5000 | 01/06/2010 | 01/07/2010 | https://pubmed.ncbi.nlm.nih.gov/23026444/ |
Adaptation to cellular stress in cortical regions involved in Parkinson's disease | Rehana K, Leak, PhD
Duquesne University, Pittsburgh, PA | 5000 | 01/06/2010 | 01/07/2010 | https://pubmed.ncbi.nlm.nih.gov/18675914/ |
Effects of bright light treatment on daytime somnolence and nocturnal sleep in patients with Parkinson's disease. | Alexandar Videnovic, MD
Rush University Medical Center, Chicago, IL | 5000 | 01/06/2009 | 01/07/2009 | |
Effects of autoimmune neuroinflammation on nigral dopaminergic neurons | Malu Tansey, PhD
Emory University School of Medicine,
Atlanta, GA | 5000 | 01/06/2009 | 01/07/2009 | https://pmc.ncbi.nlm.nih.gov/articles/PMC3639751/ |
THAP1 sequence variants as risk factors for primary dystonia | Mark LeDoux, MD, PhD
University of Tennessee Health
Sciences Center | 5000 | 01/06/2009 | 01/07/2009 | https://pubmed.ncbi.nlm.nih.gov/22229127/ |
Electrical activity of the subthalamic nucleus in early Parkinson's disease | Courtney Harrison (now Bradenham), BS and P. David Charles, MD
Vanderbilt University School of Medicine, TN | 5000 | 01/06/2008 | 01/07/2008 | https://pubmed.ncbi.nlm.nih.gov/21542021/ |
Effect of TorsinA on dopamine transporter and dopamine D2 receptors
| Aygul Balcioglu, PhD
Harvard Medical School,
Massachusetts General Hospital | 5000 | 01/06/2008 | 01/07/2008 | https://pubmed.ncbi.nlm.nih.gov/20132487/ |
Neuroprotection by vector-based RNA interference against PINK1 deficiency-induced dopaminergic neuron apoptosis | Hao Deng, MD, PhD
Baylor College of Medicine, Houston, TX | 5000 | 01/06/2007 | 01/07/2007 | https://pubmed.ncbi.nlm.nih.gov/17482357/ |
Studies on the role of COX-2 inhibitors on the survival of human and rat progenitor cells in animal models of Parkinson's disease | Ming Yang, PhD
Department of Neurology,
Jefferson Hospital of Neuroscience, Philadelphia, PA | 5000 | 01/06/2005 | 01/06/2006 | https://pubmed.ncbi.nlm.nih.gov/19824823/ |
Genetic localization of blepharospasm: analysis of Ashkenazi Jewish patients | Susan Bressman, PhD
Department of Neurology,
Beth Israel Medical Center, NY | 10000 | 01/06/2004 | 01/06/2005 | https://pubmed.ncbi.nlm.nih.gov/18267263/ |
Study of molecular defects of dystonia-causing mutations in TorsinA | Phuong Pham, PhD
PMDI,
Long Beach Memorial Center, Long Beach, CA | 10000 | 01/06/2004 | 01/06/2005 | |
Analysis of beta-glucocerebrosidase mutations in Parkinson's disease | Lorraine Clark, PhD
Department of Pathology,
Columbia University, NY | 5000 | 01/06/2004 | 01/07/2004 | https://pubmed.ncbi.nlm.nih.gov/15517591/ |
bottom of page